Vascarta is a drug development company with novel transdermal technology and a seasoned management team.
Vascarta has raised $50K in total funding. The most recent round was Debt Financing. The last funding was announced in March 2022.
Vascarta is headquartered in Summit, United States.
Vascarta is a drug development company with novel transdermal technology and a seasoned management team.
Vascarta is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vascarta — Funding & Investors." VCBacked, March 10, 2022, https://www.vcbacked.co/company/vascarta. Accessed August 14, 2026.
VCBacked. (2022). Vascarta — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/vascarta
{{cite web |title=Vascarta — Funding & Investors |url=https://www.vcbacked.co/company/vascarta |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated